Oxycodone hydrochloride controlled‐release tablets (OxyContin?): post‐marketing surveillance (PMS) study for relieving moderate to severe non‐cancer pain

作者：Huang Yuguang; Fan Bifa; Fang Wenxue; Du Dongping; Xu Hua; Zhu Shengmei; Zhao Guodong; Xu Meng; Luo Rongcheng; Lu Zhenhe; Xu Jianguo; Ni Jiaxiang; Zheng Baosen; Song Wenge; Lin Jian; Cui Jianjun; Chen Zhendong

来源：European Journal of Pain Supplements, 2007, S1: 41-47.

DOI：10.1016/S1754-3207(08)60011-5

• Oxycodone CR tablets
• Non-cancer pain
• PMS
• Pain management

Objective: To evaluate the efficacy and safety of oxycodone hydrochloride controlled‐release (CR) tablets (Oxycontin?, Mundipharma International Limited, Cambridge, UK), 5 mg, 10 mg, 20 mg, and 40 mg

• 单位
  北京协和医学院; 北京大学